spacer
home > ict > our clients
OUR CLIENTS
<><><><><><><><><><><><><><><><><><><><><><><> 

Helvoet Pharma
helvoetpharma.com/en

Almac
http://www.almacgroup.com/
 
 
Bormioli Rocco
http://www.bormiolirocco.com/

Brecon Pharmaceuticals
http://www.brecon-pharm.co.uk/


BASF
http://www.corporate.basf.com/
Burkert
http://www.buerkert.com/

Cool Logistics
http://www.cool-logistics.com/

Domino Printing
www.domino-printing.com/uk

Fisher Scientific
http://www.fisher.co.uk/
IMA
http://www.ima.it/

Ingenia Technology
http://www.ingeniatechnology.com/
JDSU
http://www.jdsu.com/

Maxim Pharmaceuticals

Patheon
http://www.patheon.com/

QunetiQ
http://www.qinetiq.com/

Sun Chemical
http://www.sunchemical.com/

Sofrigam
http://www.sofrigam.com/

Weiler
http://www.weilercorp.com/

Ypsomed
http://www.ypsomed.com/
Soft Box Systems
http://www.softboxsystems.co.uk/

SigPack
sigpackinternationallive.screenlight.ch/eng/index.asp
Bosch
http://www.bosch.de/
Safechem
http://www.safechem.co.uk/
Rexam
http://www.rexam.com/

Pill Protect
http://www.pillprotect.com/

Aesica
http://www.aesica-pharma.co.uk/

Bag HealthCare
http://www.bag-healthcare.com/

Bang & Olufsen
http://www.bang-olufsen.com/

Solvay
http://www.solvay.com/

Sensitech
http://www.sensitech.com/
HPA
http://www.hpa.org.uk/

CurTec
http://www.curtec.com/

SMi
http://www.smi-online.co.uk/

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November
 
Industry Events

BioPartnering North America™

26-28 February 2012, Vancouver Convention Centre, Vancouver, BC, Canada

BioPartnering North America 2012 (BPN) in Vancouver, Canada brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
More info >>

 
News and Press Releases

AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC

AMRI, a global contract services organization, announced today that it has entered into a preferred provider agreement with BioPontis Alliance LLC. The agreement is aimed at supporting BioPontis’ mission to bridge the gap between early-stage research and technologies being discovered and developed in academia and other research entities. AMRI will provide its services in small molecule discovery, development, and manufacturing in BioPontis’ drug discovery research programs. The agreement also supports the need for proof-of-concept data that is required in the current pharmaceutical company licensing environment. The goal of BioPontis Alliance is to identify promising early stage product opportunities and utilize a preferred network of CROs and leading research companies to apply appropriate expertise to develop these opportunities enough to attract pharmaceutical company licensing partners.  
More info >>

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.